Appendix 2—table 46. Antidepressant Non-user Cohort (All Regions) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| All Antidepressant Non-users by BP: Unmatched | All Antidepressant Non-users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 1,536,048 | 100.0% | 1,422,938 | 92.6% | 113,110 | 7.4% | 224,804 | 100.0% | 112,402 | 50.0% | 112,402 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 89,565 | 5.8% | 89,486 | 6.3% | 79 | 0.1% | <0.001 | 155 | 0.1% | 76 | 0.1% | 79 | 0.1% | 1.00 |
| 21-40 | 315,593 | 20.5% | 314,815 | 22.1% | 778 | 0.7% | 1,562 | 0.7% | 784 | 0.7% | 778 | 0.7% | ||
| 41-50 | 233,336 | 15.2% | 230,961 | 16.2% | 2,375 | 2.1% | 4,746 | 2.1% | 2,371 | 2.1% | 2,375 | 2.1% | ||
| 51-60 | 333,650 | 21.7% | 314,109 | 22.1% | 19,541 | 17.3% | 39,072 | 17.4% | 19,536 | 17.4% | 19,536 | 17.4% | ||
| 61-70 | 296,182 | 19.3% | 254,286 | 17.9% | 41,896 | 37.0% | 83,664 | 37.2% | 41,834 | 37.2% | 41,830 | 37.2% | ||
| 71-80 | 169,295 | 11.0% | 136,746 | 9.6% | 32,549 | 28.8% | 64,163 | 28.5% | 32,073 | 28.5% | 32,090 | 28.5% | ||
| ≥81 | 98,427 | 6.4% | 82,535 | 5.8% | 15,892 | 14.1% | 31,442 | 14.0% | 15,728 | 14.0% | 15,714 | 14.0% | ||
| Gender | ||||||||||||||
| Female | 1,109,580 | 72.2% | 1,004,112 | 70.6% | 105,468 | 93.2% | <0.001 | 209,510 | 93.2% | 104,743 | 93.2% | 104,767 | 93.2% | 0.84 |
| Male | 426,468 | 27.8% | 418,826 | 29.4% | 7,642 | 6.8% | 15,294 | 6.8% | 7,659 | 6.8% | 7,635 | 6.8% | ||
| Region | ||||||||||||||
| Midwest | 335,508 | 21.8% | 315,179 | 22.1% | 20,329 | 18.0% | <0.001 | 40,548 | 18.0% | 20,274 | 18.0% | 20,274 | 18.0% | 1.00 |
| Northeast | 383,023 | 24.9% | 356,184 | 25.0% | 26,839 | 23.7% | 53,590 | 23.8% | 26,795 | 23.8% | 26,795 | 23.8% | ||
| South | 596,029 | 38.8% | 552,754 | 38.8% | 43,275 | 38.3% | 85,440 | 38.0% | 42,720 | 38.0% | 42,720 | 38.0% | ||
| West | 221,488 | 14.4% | 198,821 | 14.0% | 22,667 | 20.0% | 45,226 | 20.1% | 22,613 | 20.1% | 22,613 | 20.1% | ||
| Insurance | ||||||||||||||
| Commercial | 707,675 | 46.1% | 672,990 | 47.3% | 34,685 | 30.7% | <0.001 | 69,354 | 30.9% | 34,675 | 30.8% | 34,679 | 30.9% | 1.00 |
| Dual | 54,836 | 3.6% | 44,281 | 3.1% | 10,555 | 9.3% | 19,871 | 8.8% | 9,927 | 8.8% | 9,944 | 8.8% | ||
| Medicaid | 486,446 | 31.7% | 463,857 | 32.6% | 22,589 | 20.0% | 45,057 | 20.0% | 22,537 | 20.1% | 22,520 | 20.0% | ||
| Medicare | 287,091 | 18.7% | 241,810 | 17.0% | 45,281 | 40.0% | 90,522 | 40.3% | 45,263 | 40.3% | 45,259 | 40.3% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 605,256 | 39.4% | 572,701 | 40.2% | 32,555 | 28.8% | <0.001 | 64,959 | 28.9% | 32,483 | 28.9% | 32,476 | 28.9% | 0.97 |
| Yes | 930,792 | 60.6% | 850,237 | 59.8% | 80,555 | 71.2% | 159,845 | 71.1% | 79,919 | 71.1% | 79,926 | 71.1% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.87 | 1.60 | 0.85 | 1.58 | 1.06 | 1.84 | <0.001 | 1.06 | 1.82 | 1.05 | 1.81 | 1.06 | 1.83 | 0.57 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.